| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | NUT | 1.66e-06 | 5 | 104 | 3 | IPR024310 | |
| Domain | NUT_N | 1.66e-06 | 5 | 104 | 3 | IPR024309 | |
| Domain | NUT | 1.66e-06 | 5 | 104 | 3 | PF12881 | |
| Domain | COMP | 9.18e-05 | 3 | 104 | 2 | PF11598 | |
| Domain | Thbs/COMP_coiled-coil | 9.18e-05 | 3 | 104 | 2 | IPR024665 | |
| Domain | SCAN | 2.67e-04 | 56 | 104 | 4 | SM00431 | |
| Domain | TSP_3 | 3.04e-04 | 5 | 104 | 2 | PF02412 | |
| Domain | TSP3 | 3.04e-04 | 5 | 104 | 2 | PS51234 | |
| Domain | TSP_CTER | 3.04e-04 | 5 | 104 | 2 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 3.04e-04 | 5 | 104 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 3.04e-04 | 5 | 104 | 2 | IPR028974 | |
| Domain | - | 3.04e-04 | 5 | 104 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 3.04e-04 | 5 | 104 | 2 | IPR008859 | |
| Domain | TSP_C | 3.04e-04 | 5 | 104 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 3.04e-04 | 5 | 104 | 2 | IPR003367 | |
| Domain | SCAN_BOX | 3.06e-04 | 58 | 104 | 4 | PS50804 | |
| Domain | SCAN | 3.06e-04 | 58 | 104 | 4 | PF02023 | |
| Domain | SCAN_dom | 3.06e-04 | 58 | 104 | 4 | IPR003309 | |
| Domain | C2H2_Znf_fam | 3.12e-04 | 24 | 104 | 3 | IPR027775 | |
| Domain | Retrov_capsid_C | 3.26e-04 | 59 | 104 | 4 | IPR008916 | |
| Domain | BRK | 4.54e-04 | 6 | 104 | 2 | SM00592 | |
| Domain | Pectin_lyas_fold | 4.54e-04 | 6 | 104 | 2 | IPR012334 | |
| Domain | PbH1 | 4.54e-04 | 6 | 104 | 2 | SM00710 | |
| Domain | BRK_domain | 4.54e-04 | 6 | 104 | 2 | IPR006576 | |
| Domain | - | 4.54e-04 | 6 | 104 | 2 | 2.160.20.10 | |
| Domain | PbH1 | 4.54e-04 | 6 | 104 | 2 | IPR006626 | |
| Domain | BRK | 4.54e-04 | 6 | 104 | 2 | PF07533 | |
| Domain | Pectin_lyase_fold/virulence | 8.41e-04 | 8 | 104 | 2 | IPR011050 | |
| Domain | VitD_rcpt | 2.68e-03 | 14 | 104 | 2 | IPR000324 | |
| Domain | SANT | 2.72e-03 | 50 | 104 | 3 | SM00717 | |
| Domain | SANT/Myb | 3.04e-03 | 52 | 104 | 3 | IPR001005 | |
| Domain | Cadherin_CS | 3.23e-03 | 109 | 104 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 3.67e-03 | 113 | 104 | 4 | PS00232 | |
| Domain | Cadherin | 3.67e-03 | 113 | 104 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 3.79e-03 | 114 | 104 | 4 | PS50268 | |
| Domain | - | 3.79e-03 | 114 | 104 | 4 | 2.60.40.60 | |
| Domain | CA | 3.91e-03 | 115 | 104 | 4 | SM00112 | |
| Domain | Cadherin-like | 4.03e-03 | 116 | 104 | 4 | IPR015919 | |
| Domain | Cadherin | 4.28e-03 | 118 | 104 | 4 | IPR002126 | |
| Domain | GAGE | 4.94e-03 | 19 | 104 | 2 | IPR031320 | |
| Domain | GAGE | 4.94e-03 | 19 | 104 | 2 | SM01379 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ENGASE EPPK1 SPEG IRAK1 CHD8 SFI1 FASN SLC38A10 CELSR3 MTMR14 KANK3 PKD1 ZNF500 OGDHL BRAT1 HTT PCNT | 5.51e-08 | 1105 | 108 | 17 | 35748872 |
| Pubmed | CTCF-dependent chromatin insulator is linked to epigenetic remodeling. | 9.55e-06 | 2 | 108 | 2 | 16949368 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31757932 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18550811 | ||
| Pubmed | Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter. | 9.55e-06 | 2 | 108 | 2 | 18769028 | |
| Pubmed | CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome. | 9.55e-06 | 2 | 108 | 2 | 20453063 | |
| Pubmed | Pathogenicity analysis of novel variations in Chinese Han patients with polycystic kidney disease. | 9.55e-06 | 2 | 108 | 2 | 28578020 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27219007 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17603073 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24211491 | ||
| Pubmed | DNA methylation profiling in human Huntington's disease brain. | 9.55e-06 | 2 | 108 | 2 | 26953320 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11919560 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | STAG1 ARHGEF5 ADNP2 CHD8 CHD7 FBXO38 NFATC2IP ZBTB10 ZBTB11 DDX41 | 2.07e-05 | 608 | 108 | 10 | 36089195 |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 30108144 | ||
| Pubmed | Characterization of PKD protein-positive exosome-like vesicles. | 2.86e-05 | 3 | 108 | 2 | 19158352 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 38742641 | ||
| Pubmed | Analysis of the polycystin complex (PCC) in human urinary exosome-like vesicles (ELVs). | 2.86e-05 | 3 | 108 | 2 | 32001768 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 37717980 | ||
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 2.86e-05 | 3 | 108 | 2 | 33910854 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 25499215 | ||
| Pubmed | Expression of polycystins and fibrocystin on primary cilia of lung cells. | 2.86e-05 | 3 | 108 | 2 | 25367197 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 28533432 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 30277262 | ||
| Pubmed | Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. | 2.86e-05 | 3 | 108 | 2 | 10968783 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 37845212 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12970362 | ||
| Pubmed | PTPN23 FBXO11 GOLM1 CHD7 PABPN1L ZNF496 AKAP12 ZBTB10 FMN2 OGDHL TANGO2 PARPBP PCNT | 3.25e-05 | 1084 | 108 | 13 | 11544199 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 3.32e-05 | 394 | 108 | 8 | 27248496 | |
| Pubmed | 3.78e-05 | 653 | 108 | 10 | 22586326 | ||
| Pubmed | 5.03e-05 | 418 | 108 | 8 | 34709266 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 17369526 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 23285124 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 26019035 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 32475690 | ||
| Pubmed | Loss of oriented cell division does not initiate cyst formation. | 5.71e-05 | 4 | 108 | 2 | 19959710 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 6.13e-05 | 430 | 108 | 8 | 35044719 | |
| Pubmed | Quantitative interaction proteomics of neurodegenerative disease proteins. | 6.98e-05 | 323 | 108 | 7 | 25959826 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 30622267 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 21685914 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 21041232 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 19774080 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 18219272 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 18467703 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 7760852 | ||
| Pubmed | Enhanced tonic GABAA inhibition in typical absence epilepsy. | 9.50e-05 | 5 | 108 | 2 | 19966779 | |
| Pubmed | Loss of polycystin-1 inhibits Bicc1 expression during mouse development. | 1.42e-04 | 6 | 108 | 2 | 24594709 | |
| Pubmed | CHARGE and Kabuki syndromes: a phenotypic and molecular link. | 1.42e-04 | 6 | 108 | 2 | 24705355 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 17575307 | ||
| Pubmed | Expression of (cac)n/(gtg)n simple repetitive sequences in mRNA of human lymphocytes. | 1.42e-04 | 6 | 108 | 2 | 7505766 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDXDC1 OGFR PTPN23 VTA1 SMOC1 CTSA AKAP12 GTF2F1 FASN AP2B1 ZFYVE19 EIF3B BRAT1 HTT | 1.68e-04 | 1455 | 108 | 14 | 22863883 |
| Pubmed | STAG1 ADNP2 FBXO11 SLC6A1 CELSR3 GAR1 AP2B1 PKD1 FMN2 NR1H2 ZBTB11 PBXIP1 PCNT | 1.79e-04 | 1285 | 108 | 13 | 35914814 | |
| Pubmed | 1.93e-04 | 36 | 108 | 3 | 33737325 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 25203322 | ||
| Pubmed | RNF152 positively regulates TLR/IL-1R signaling by enhancing MyD88 oligomerization. | 1.99e-04 | 7 | 108 | 2 | 31930677 | |
| Pubmed | The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1). | 1.99e-04 | 7 | 108 | 2 | 10860780 | |
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 2.64e-04 | 8 | 108 | 2 | 24460873 | |
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 20215348 | ||
| Pubmed | 3.39e-04 | 9 | 108 | 2 | 18172001 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.77e-04 | 582 | 108 | 8 | 20467437 | |
| Pubmed | 4.82e-04 | 116 | 108 | 4 | 30804394 | ||
| Pubmed | 5.15e-04 | 210 | 108 | 5 | 16537572 | ||
| Pubmed | LIS1 regulates CNS lamination by interacting with mNudE, a central component of the centrosome. | 5.16e-04 | 11 | 108 | 2 | 11163258 | |
| Pubmed | 5.98e-04 | 217 | 108 | 5 | 34048709 | ||
| Pubmed | 6.12e-04 | 332 | 108 | 6 | 37433992 | ||
| Pubmed | 6.18e-04 | 12 | 108 | 2 | 16219912 | ||
| Pubmed | 6.44e-04 | 54 | 108 | 3 | 18495661 | ||
| Pubmed | BRPF3 ADNP2 IRAK1 ZKSCAN2 CHD8 SIPA1 ZNF526 CTCF ZBTB10 FMN2 DDX41 | 7.15e-04 | 1116 | 108 | 11 | 31753913 | |
| Pubmed | 8.32e-04 | 634 | 108 | 8 | 34591612 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 8.34e-04 | 59 | 108 | 3 | 16083285 | |
| Pubmed | 8.48e-04 | 963 | 108 | 10 | 28671696 | ||
| Pubmed | 8.66e-04 | 638 | 108 | 8 | 33239621 | ||
| Pubmed | 9.77e-04 | 15 | 108 | 2 | 10704353 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOC2L ADNP2 PTPN23 VTA1 CHD8 CHD7 STAU1 FASN AP2B1 ZBTB10 EIF3B DDX41 | 1.02e-03 | 1353 | 108 | 12 | 29467282 |
| Pubmed | The interactome of the prostate-specific protein Anoctamin 7. | 1.11e-03 | 65 | 108 | 3 | 32176628 | |
| Pubmed | 1.11e-03 | 16 | 108 | 2 | 37683603 | ||
| Pubmed | 1.11e-03 | 16 | 108 | 2 | 10932191 | ||
| Pubmed | 1.11e-03 | 16 | 108 | 2 | 9409616 | ||
| Pubmed | Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. | 1.11e-03 | 16 | 108 | 2 | 22780989 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.26e-03 | 150 | 108 | 4 | 28242625 | |
| Pubmed | MicroRNA-140 plays dual roles in both cartilage development and homeostasis. | 1.26e-03 | 17 | 108 | 2 | 20466812 | |
| Pubmed | HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. | 1.26e-03 | 17 | 108 | 2 | 1559613 | |
| Pubmed | 1.26e-03 | 17 | 108 | 2 | 16472605 | ||
| Pubmed | Autism risk gene POGZ promotes chromatin accessibility and expression of clustered synaptic genes. | 1.26e-03 | 17 | 108 | 2 | 34879283 | |
| Pubmed | 1.26e-03 | 17 | 108 | 2 | 10982846 | ||
| Pubmed | 1.42e-03 | 18 | 108 | 2 | 9315662 | ||
| Pubmed | 1.58e-03 | 19 | 108 | 2 | 23920377 | ||
| Pubmed | 1.69e-03 | 878 | 108 | 9 | 37223481 | ||
| Pubmed | 1.75e-03 | 20 | 108 | 2 | 22632967 | ||
| Pubmed | Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. | 1.75e-03 | 20 | 108 | 2 | 17251353 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.80e-03 | 410 | 108 | 6 | 26949251 | |
| Pubmed | 1.93e-03 | 21 | 108 | 2 | 25113559 | ||
| Pubmed | Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease. | 1.93e-03 | 21 | 108 | 2 | 27591083 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.99e-03 | 170 | 108 | 4 | 16159877 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 2.01e-03 | 80 | 108 | 3 | 10716726 | |
| Pubmed | 2.01e-03 | 568 | 108 | 7 | 9110174 | ||
| Pubmed | 2.12e-03 | 22 | 108 | 2 | 20965718 | ||
| Pubmed | Nuclear receptors in Leydig cell gene expression and function. | 2.12e-03 | 22 | 108 | 2 | 20375256 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 2.13e-03 | 736 | 108 | 8 | 29676528 | |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | 2.14e-03 | 574 | 108 | 7 | 8619474 | |
| Pubmed | 2.32e-03 | 23 | 108 | 2 | 26002199 | ||
| Cytoband | 20q13.1 | 1.54e-06 | 10 | 109 | 3 | 20q13.1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZSCAN4 ADNP2 ZKSCAN2 ZNF496 ZNF526 CTCF ZNF641 ZNF500 ZBTB10 ZBTB11 | 2.93e-04 | 718 | 67 | 10 | 28 |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 9.98e-04 | 53 | 67 | 3 | 532 | |
| Coexpression | GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP | 1.86e-05 | 200 | 107 | 7 | M5833 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN | 1.86e-05 | 200 | 107 | 7 | M5693 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-07 | 189 | 109 | 7 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-07 | 189 | 109 | 7 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 169 | 109 | 6 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 169 | 109 | 6 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 169 | 109 | 6 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 169 | 109 | 6 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.04e-06 | 171 | 109 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 4.32e-06 | 173 | 109 | 6 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.09e-06 | 178 | 109 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.96e-06 | 188 | 109 | 6 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 198 | 109 | 6 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 198 | 109 | 6 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.62e-05 | 142 | 109 | 5 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | PBMC-Mild-cDC_7|Mild / Compartment, Disease Groups and Clusters | 2.62e-05 | 142 | 109 | 5 | 58f66f35646f281e64d634e6c26adbd1d4e6c830 | |
| ToppCell | Endothelial-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.36e-05 | 165 | 109 | 5 | b6893882472aeb0d18e26f47eaec9d53688afcde | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 167 | 109 | 5 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 167 | 109 | 5 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | Endothelial-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 5.84e-05 | 168 | 109 | 5 | 4977c3837fbb1f36c89fddd5764e37290ac25ad8 | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.01e-05 | 169 | 109 | 5 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.35e-05 | 171 | 109 | 5 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.53e-05 | 172 | 109 | 5 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.53e-05 | 172 | 109 | 5 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 174 | 109 | 5 | 76310c0af1d7df6a4de3816838b2ac2892f68746 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.08e-05 | 175 | 109 | 5 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 7.28e-05 | 176 | 109 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 7.28e-05 | 176 | 109 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-05 | 177 | 109 | 5 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-05 | 177 | 109 | 5 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 8.09e-05 | 180 | 109 | 5 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.09e-05 | 180 | 109 | 5 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-05 | 183 | 109 | 5 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-05 | 183 | 109 | 5 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 8.97e-05 | 184 | 109 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 185 | 109 | 5 | 62cfcb0e2a9e6718e6b200dfbb1a81eaead229b5 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 9.20e-05 | 185 | 109 | 5 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 9.20e-05 | 185 | 109 | 5 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 185 | 109 | 5 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 186 | 109 | 5 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 9.44e-05 | 186 | 109 | 5 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.44e-05 | 186 | 109 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.68e-05 | 187 | 109 | 5 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-05 | 187 | 109 | 5 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.68e-05 | 187 | 109 | 5 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.68e-05 | 187 | 109 | 5 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.93e-05 | 188 | 109 | 5 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-05 | 188 | 109 | 5 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 9.93e-05 | 188 | 109 | 5 | 3df5a5b645403914c4d0506e2d93f8a8a98e3fa6 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-05 | 188 | 109 | 5 | d534ed9870405a3c1075962308f72b460aed17bf | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.93e-05 | 188 | 109 | 5 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-04 | 190 | 109 | 5 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 1.04e-04 | 190 | 109 | 5 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 191 | 109 | 5 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 191 | 109 | 5 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 192 | 109 | 5 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 192 | 109 | 5 | 945153c41dde6e90d103206955e1707b54eb0665 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 192 | 109 | 5 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 192 | 109 | 5 | 6ab50579c63f31ca2cd41063a99b129f11c07510 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.10e-04 | 192 | 109 | 5 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 192 | 109 | 5 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 193 | 109 | 5 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.12e-04 | 193 | 109 | 5 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 193 | 109 | 5 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 193 | 109 | 5 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-04 | 194 | 109 | 5 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-04 | 194 | 109 | 5 | 920955e775617d6156c5ee8b90d2cecd01a70e12 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-04 | 194 | 109 | 5 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-04 | 194 | 109 | 5 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-04 | 194 | 109 | 5 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 195 | 109 | 5 | 4db30b3bc65c25626f828cd4f867f20c71809898 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-04 | 196 | 109 | 5 | fe2dd3a93fe22da93e24a400e154a68757985fc8 | |
| ToppCell | distal-3-Epithelial-Ionocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-04 | 196 | 109 | 5 | 6ed146481dd04fb271eadc47d68eb3ae38986db6 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 196 | 109 | 5 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | distal-Endothelial-Lymphatic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-04 | 196 | 109 | 5 | b0f23dc802a2c2a56a08d398a464ea78b58ade4c | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 197 | 109 | 5 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 197 | 109 | 5 | 31bec97c3952c48031bd66a5dad16a70a61519c3 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 198 | 109 | 5 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 198 | 109 | 5 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 109 | 5 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Mesothelial-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.33e-04 | 200 | 109 | 5 | b33901d91b3af5c0cf310eede30ce03af90c9783 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 109 | 5 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 109 | 5 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.33e-04 | 200 | 109 | 5 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-04 | 200 | 109 | 5 | 23bc13983f6bdf95e63109b8bc14c4921ca85c3a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 109 | 5 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 109 | 5 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-04 | 200 | 109 | 5 | d276062545ecc428a28b12a74f06f3c6bbcff4a3 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 109 | 5 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 4.26e-07 | 199 | 107 | 9 | 4633_DN | |
| Disease | Intellectual Disability | 3.48e-05 | 447 | 106 | 9 | C3714756 | |
| Disease | Mental Retardation, Psychosocial | 1.49e-04 | 139 | 106 | 5 | C0025363 | |
| Disease | Profound Mental Retardation | 1.49e-04 | 139 | 106 | 5 | C0020796 | |
| Disease | Mental deficiency | 1.49e-04 | 139 | 106 | 5 | C0917816 | |
| Disease | cancer antigen 15.3 measurement | 2.65e-04 | 7 | 106 | 2 | EFO_0010585 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 2.65e-04 | 7 | 106 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Hepatomegaly | 9.78e-04 | 54 | 106 | 3 | C0019209 | |
| Disease | isoleucine measurement | 1.09e-03 | 56 | 106 | 3 | EFO_0009793 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.30e-03 | 15 | 106 | 2 | C3645536 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.48e-03 | 16 | 106 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | mean arterial pressure | 2.19e-03 | 499 | 106 | 7 | EFO_0006340 | |
| Disease | osteoarthritis (biomarker_via_orthology) | 2.57e-03 | 21 | 106 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | colorectal carcinoma (is_implicated_in) | 2.82e-03 | 22 | 106 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | breast cancer, COVID-19 | 2.82e-03 | 22 | 106 | 2 | MONDO_0007254, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQDLGRQDPPLAEDI | 1051 | O00555 | |
| IVDENSNLLPPGEEG | 401 | Q6P461 | |
| PPGVQQQAEEEEGTA | 106 | A6NDY0 | |
| RAGEQAQPPGDQEPE | 756 | Q6PJG6 | |
| LPQDSGQRVEEVPGD | 66 | Q5SNV9 | |
| GEQNIPRVLNEDELP | 476 | Q9HCK8 | |
| EAAEERAEPGQQQPA | 11 | P55884 | |
| VPAQGEAPGEQARDE | 101 | P55884 | |
| EQPQVIPSQGDLLGD | 616 | P63010 | |
| ANGEVETLEQGELPP | 171 | P49711 | |
| GPQHEEKQDRDGNIP | 716 | Q86TB3 | |
| GPEDVLQPVQRAEAE | 1061 | Q02952 | |
| RQGEEVQERAEPPGH | 46 | Q9UNA0 | |
| QGEELPPEELQESQG | 206 | Q12774 | |
| LVPNPGQEDADRDGV | 486 | P49747 | |
| NNGEVTQPPRILGEA | 261 | Q9UKB5 | |
| ELPAGPQGDAAVLEQ | 801 | Q9ULD4 | |
| QESPRREPEQLGEDV | 541 | Q8IYM0 | |
| ELHGEPTRIQEDPNG | 171 | Q8N126 | |
| QGQPPTLDIEDTEGQ | 266 | A6NFT4 | |
| GDPQAIQERLIPGQQ | 486 | Q9P2D1 | |
| LQEAHPGEPQEDRGI | 91 | Q9NZA1 | |
| GAEDQRHGEEQPPIL | 986 | Q6IQ32 | |
| QPRGAEPEAQDVDPR | 396 | Q96K21 | |
| QPGADQIDVVQPGAD | 526 | Q9H0J4 | |
| DGENILCDNRNEPPQ | 516 | Q9NWS1 | |
| EVEAGNGIPELPQLV | 1411 | Q9H3S7 | |
| EQVAGPLGQNLEVEP | 41 | Q96RI1 | |
| PTDNQDIEPGQEREG | 36 | O60829 | |
| IGNAEGEPVVPERQI | 241 | Q9NXN4 | |
| NPDGNLQERAQVDPL | 1121 | P23467 | |
| NQPPQELGLGELLEE | 21 | Q8NCE2 | |
| QQIGSEDGEPPQQRV | 6 | P14672 | |
| EDGEPPQQRVTGTLV | 11 | P14672 | |
| EEQEGGVPQRERPEV | 276 | Q6ZT52 | |
| IPEDGAAARAPEQVQ | 871 | Q9ULD0 | |
| GDEDEEPQSPRIQNI | 71 | Q6P996 | |
| GDEDEEPQSPRIQNI | 71 | Q6P474 | |
| IRDPEQGLEGSLEQP | 611 | Q96MY7 | |
| QQLDLEIGEAAPPGQ | 136 | Q9Y5F7 | |
| PAAVDPDVGINGVQN | 161 | Q9BZA7 | |
| RGDEDDIPLGPQSNV | 71 | Q9UJV9 | |
| EQLQRGPNQPVESDE | 576 | P51617 | |
| PGELQQLAQGPEDEL | 726 | Q9Y3T9 | |
| GPRDSQQAPLDGEVE | 1516 | O95613 | |
| LEEPRGQQEVLQDQP | 96 | P26010 | |
| GEAAPDQDEIQRLPG | 26 | P10619 | |
| PVDVDEEQAGPSGLQ | 571 | Q6PIJ6 | |
| GQPQDEDEEATGILP | 596 | P42858 | |
| REIADDPLQEPGAQQ | 486 | Q0VDD7 | |
| PLPQERNNVGERDDD | 66 | Q86XK2 | |
| APELLQGQSEDEQPD | 86 | Q68DX3 | |
| RQELLEEEGEGQEPP | 266 | Q6ZU35 | |
| EEGRQALEPLPQGIQ | 1296 | Q3T8J9 | |
| EPEAEAEPQQVAQGR | 531 | Q6NY19 | |
| VPPQGLELADREGQD | 491 | A6NN90 | |
| QPEGGQEQSRVLGPE | 901 | Q02388 | |
| PPSGLLEVQEDAQVG | 396 | Q9UJ99 | |
| PEAGTQEEQEDQEPR | 26 | Q8NFI3 | |
| VNEEPQRDRLPQEPG | 261 | Q8NBJ4 | |
| EGPERDQLVIPDGQE | 316 | Q8NBJ4 | |
| LVVEASDQGQEPGPR | 511 | Q9NYQ7 | |
| GPEGNLNQIVTEPDA | 61 | Q5XKR9 | |
| ERGGPEVQQVPAGER | 476 | P49327 | |
| QRLGEEPEEEAQGPD | 376 | Q9NZ56 | |
| EEAQLDRPGQGIAVP | 476 | Q9HBR0 | |
| EPEQGEVGKRPGQAQ | 551 | Q9HBR0 | |
| ERAVPENGNLGPIQA | 681 | Q9Y597 | |
| ELQPGGPVQDAENLL | 531 | P98161 | |
| EPQDAGPLERSQGDE | 351 | Q9NZT2 | |
| EEGEPLEPGELQLNE | 286 | P07332 | |
| AAGQGAERDVPVPQQ | 651 | Q8IVF1 | |
| AAGQGAERDVPDPQE | 651 | B1AL46 | |
| GQEAAREVPDPQQRV | 531 | A1L443 | |
| GQEAAREVPDPQQRV | 516 | Q5VZR2 | |
| RLQEDPEGTENPLGV | 206 | Q13239 | |
| GQDQGPPERVVLLGE | 61 | Q9NY12 | |
| EEPQEPNRLETGEAG | 171 | O75298 | |
| APQQEEGPKGVDEQS | 291 | P35269 | |
| LNREEPGPEDQEVEQ | 1186 | A8K8P3 | |
| DIVRPENGPEQPQAG | 576 | P30531 | |
| EPQDEGELFQGVDPR | 66 | O15240 | |
| PLQGGAPQEAVEEEQ | 141 | Q8N8N0 | |
| AADEGPAREEQRPIQ | 36 | Q8IW70 | |
| DRPNVQEPGRVEALQ | 381 | P55055 | |
| EEAEEAPGARPQLQD | 2576 | P58107 | |
| IEEAEEAPGARPQLQ | 3111 | P58107 | |
| IEEAEEAPGARPQLQ | 4176 | P58107 | |
| GAPDPVQDEVQGVTL | 786 | Q96FS4 | |
| EGQENVEILPSGERP | 31 | P61218 | |
| PERLPQDGDNVTVEN | 1936 | P08F94 | |
| LVQPSDGEVGNELPV | 3746 | P08F94 | |
| DGEVGNELPVQPQLV | 3751 | P08F94 | |
| RPAEPVEEENKNGNG | 26 | Q8NHU3 | |
| KPPQGQEQQGQEDEV | 236 | Q8NCF5 | |
| GVLEPGQPENDIDRI | 136 | Q8N0Z2 | |
| GFSEQEPVQGVEPLQ | 441 | Q99941 | |
| PEEPQRLLEQAEAEG | 311 | Q9UBN6 | |
| EEAQQNPREGIVIPE | 236 | Q9H4F8 | |
| EEGPEGPQRIVLQGD | 456 | A0A0J9YY54 | |
| EGPEGPQRIVLQGDN | 581 | A0A0J9YY54 | |
| LPEAEQNGEVGRQPE | 371 | O95625 | |
| QDGLREQLQAPVPPD | 246 | Q96AQ6 | |
| EPGEGPQQEVRRRDQ | 581 | Q15772 | |
| QNEPLPERLEVNGRE | 161 | O95793 | |
| TPQAGPVGIEEDNDI | 161 | Q9NP79 | |
| QRLQGLGRQGPPEEE | 1361 | O75038 | |
| PQQNGEGEPVTLFEV | 76 | Q8WVM7 | |
| VPNPLQTDRDEDGVG | 581 | P49746 | |
| IIQEENGPRPEEGGV | 221 | Q8NAM6 | |
| AQPDLSQGEENEPRV | 266 | Q96IT1 | |
| SQGEENEPRVPELQD | 271 | Q96IT1 | |
| PSRQERGGIEVEPQE | 601 | Q63HK3 | |
| TQNVGLEPELVPGAE | 91 | Q8TF50 | |
| QPPNGRGADEEVELE | 56 | Q96DT7 | |
| PAPGQEREEDQGAAE | 46 | Q8WTP9 | |
| RDAPLENEGPGIQLE | 246 | O60304 | |
| EAQLPDPAIEDQGGE | 201 | Q6ICL3 | |
| GAEPQVERGSQEERP | 36 | Q96N77 | |
| EEVIEINRADPRPNG | 651 | Q14003 |